NEO
Income statement / Annual
Last year (2024), NeoGenomics, Inc.'s total revenue was $660.57 M,
an increase of 11.65% from the previous year.
In 2024, NeoGenomics, Inc.'s net income was -$78.73 M.
See NeoGenomics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$660.57 M |
$591.64 M |
$509.73 M |
$484.33 M |
$444.45 M |
$408.83 M |
$276.74 M |
$258.61 M |
$244.08 M |
$99.80 M |
| Cost of Revenue |
$370.47 M
|
$347.04 M
|
$321.83 M
|
$297.27 M
|
$258.56 M
|
$211.99 M
|
$149.48 M
|
$138.30 M
|
$133.70 M
|
$56.05 M
|
| Gross Profit |
$290.10 M
|
$244.60 M
|
$187.90 M
|
$187.06 M
|
$185.89 M
|
$196.84 M
|
$127.27 M
|
$120.32 M
|
$110.38 M
|
$43.76 M
|
| Gross Profit Ratio |
0.44
|
0.41
|
0.37
|
0.39
|
0.42
|
0.48
|
0.46
|
0.47
|
0.45
|
0.44
|
| Research and Development Expenses |
$31.16 M
|
$27.31 M
|
$30.33 M
|
$21.87 M
|
$8.23 M
|
$8.49 M
|
$3.00 M
|
$3.64 M
|
$4.65 M
|
$4.20 M
|
| General & Administrative Expenses |
$259.74 M
|
$243.10 M
|
$243.36 M
|
$221.35 M
|
$143.79 M
|
$127.99 M
|
$84.82 M
|
$88.76 M
|
$75.78 M
|
$33.63 M
|
| Selling & Marketing Expenses |
$84.65 M
|
$70.84 M
|
$67.32 M
|
$62.59 M
|
$47.86 M
|
$47.35 M
|
$29.40 M
|
$24.54 M
|
$23.91 M
|
$11.56 M
|
| Selling, General & Administrative Expenses |
$344.39 M
|
$313.04 M
|
$310.68 M
|
$283.94 M
|
$191.66 M
|
$175.34 M
|
$114.22 M
|
$113.30 M
|
$99.69 M
|
$45.19 M
|
| Other Expenses |
$0.00
|
$11.99 M
|
-$213,000.00
|
-$499,000.00
|
$11.86 M
|
-$4.63 M
|
$14,000.00
|
-$1.32 M
|
$3.46 M
|
$2.00 M
|
| Operating Expenses |
$375.55 M
|
$352.34 M
|
$341.00 M
|
$305.81 M
|
$199.89 M
|
$183.83 M
|
$117.23 M
|
$116.93 M
|
$104.34 M
|
$49.39 M
|
| Cost And Expenses |
$746.01 M
|
$699.38 M
|
$662.84 M
|
$603.08 M
|
$458.44 M
|
$395.82 M
|
$266.70 M
|
$255.23 M
|
$238.05 M
|
$105.44 M
|
| Interest Income |
$18.43 M
|
$16.90 M
|
$6.08 M
|
$3.14 M
|
$3.06 M
|
$3.71 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$6.62 M
|
$6.91 M
|
$1.51 M
|
$5.08 M
|
$7.02 M
|
$3.71 M
|
$6.23 M
|
$5.54 M
|
$10.00 M
|
$854,000.00
|
| Depreciation & Amortization |
$72.55 M
|
$72.58 M
|
$79.21 M
|
$62.07 M
|
$41.89 M
|
$35.91 M
|
$21.73 M
|
$22.59 M
|
$23.21 M
|
$7.14 M
|
| EBITDA |
-$1.51 M |
-$17.61 M |
-$78.63 M |
$52.08 M |
$34.85 M |
$43.26 M |
$31.79 M |
$26.55 M |
$29.25 M |
$3.51 M |
| EBITDA Ratio |
-0
|
-0.03
|
-0.16
|
0.09
|
0.08
|
0.09
|
0.11
|
0.1
|
0.12
|
0.04
|
| Operating Income Ratio |
-0.14
|
-0.18
|
-0.3
|
-0.02
|
-0
|
0.02
|
0.04
|
0.01
|
0.01
|
-0.06
|
| Total Other Income/Expenses Net |
$13.38 M
|
$10.64 M
|
-$1.72 M
|
$103.68 M
|
-$64,000.00
|
-$9.36 M
|
-$6.22 M
|
-$5.55 M
|
-$10.00 M
|
$1.15 M
|
| Income Before Tax |
-$78.73 M
|
-$97.10 M
|
-$159.34 M
|
-$15.08 M
|
-$14.06 M
|
$3.65 M
|
$3.82 M
|
-$3.48 M
|
-$7.42 M
|
-$4.49 M
|
| Income Before Tax Ratio |
-0.12
|
-0.16
|
-0.31
|
-0.03
|
-0.03
|
0.01
|
0.01
|
-0.01
|
-0.03
|
-0.04
|
| Income Tax Expense |
$0.00
|
-$9.13 M
|
-$15.09 M
|
-$6.73 M
|
-$18.23 M
|
-$4.36 M
|
$1.18 M
|
-$2.64 M
|
-$1.70 M
|
-$1.95 M
|
| Net Income |
-$78.73 M
|
-$87.97 M
|
-$144.25 M
|
-$8.35 M
|
$4.17 M
|
$8.01 M
|
$2.64 M
|
-$846,000.00
|
-$5.72 M
|
-$2.54 M
|
| Net Income Ratio |
-0.12
|
-0.15
|
-0.28
|
-0.02
|
0.01
|
0.02
|
0.01
|
-0
|
-0.02
|
-0.03
|
| EPS |
-0.62 |
-0.7 |
-1.16 |
-0.0696 |
0.0384 |
0.0797 |
0.0288 |
-0.0108 |
-0.0743 |
-0.0419 |
| EPS Diluted |
-0.62 |
-0.7 |
-1.16 |
-0.0696 |
0.0373 |
0.0773 |
0.0288 |
-0.0107 |
-0.0738 |
-0.0419 |
| Weighted Average Shares Out |
$126.66 M
|
$125.50 M
|
$124.22 M
|
$119.96 M
|
$108.58 M
|
$100.47 M
|
$91.57 M
|
$78.16 M
|
$77.04 M
|
$60.53 M
|
| Weighted Average Shares Out Diluted |
$126.66 M
|
$125.50 M
|
$124.22 M
|
$119.96 M
|
$111.79 M
|
$103.62 M
|
$91.57 M
|
$79.43 M
|
$77.54 M
|
$60.53 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
